- Report
- August 2025
- 190 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 185 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 180 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 190 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- August 2025
- 186 Pages
Global
From €3116EUR$3,545USD£2,695GBP
€3462EUR$3,939USD£2,995GBP
- Report
- April 2025
- 175 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- February 2025
- 200 Pages
Global
From €3947EUR$4,490USD£3,414GBP
- Report
- September 2025
- 388 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 268 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 274 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 379 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 279 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 297 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- September 2025
- 203 Pages
Global
From €5142EUR$5,850USD£4,448GBP
- Report
- June 2025
- 400 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- June 2025
- 400 Pages
Global
From €4350EUR$4,949USD£3,763GBP
- Report
- July 2025
- 118 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- March 2025
- 85 Pages
Global
From €3500EUR$4,266USD£3,133GBP
- Report
- October 2024
- 50 Pages
Global
From €2197EUR$2,500USD£1,901GBP

The Cardiac Rhythm Management (CRM) market is a segment of the cardiovascular devices industry. It includes a range of products and services used to diagnose and treat cardiac arrhythmias, or abnormal heart rhythms. These products include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and cardiac ablation systems. CRM products are used to monitor and regulate the electrical activity of the heart, helping to restore normal rhythm and improve patient outcomes.
CRM products are used in a variety of clinical settings, including hospitals, clinics, and ambulatory care centers. The market is driven by technological advancements, such as miniaturization of devices and the development of new features, as well as an increasing prevalence of cardiovascular diseases.
Notable companies in the CRM market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more